FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

A Clucas

Research Profile

Chemicals & Drugs

Anatomy

Skin

Procedures

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
C Queille-Roussel; Michel Poncet; S Mesaros; A Clucas; M Baker; A M Soloff
Comparison of the cumulative irritation potential of adapalene gel and cream with that of erythromycin/tretinoin solution and gel and erythromycin/isotretinoin gel.
E Grosshans; R Marks; J M Mascaro; H Torras; Jean Meynadier; Mohsen Alirezai; Andrew Y Finlay; Pascale Soto; Michel Poncet; M Verschoore; A Clucas
Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life.
Christopher E M Griffiths; Philippe Ancian; JD Humphries; Michel Poncet; E Rizova; S Michel; A Clucas
Adapalene 0.1% gel and adapalene 0.1% cream stimulate retinoic acid receptor mediated gene transcription without significant irritative effects in the skin of healthy human volunteers.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of A Clucas (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2001: C Queille-Roussel; Michel Poncet; S Mesaros; A Clucas; M Baker; A M Soloff
Comparison of the cumulative irritation potential of adapalene gel and cream with that of erythromycin/tretinoin solution and gel and erythromycin/isotretinoin gel.
Clinical therapeutics 2001;23(2):205-12.
1998: E Grosshans; R Marks; J M Mascaro; H Torras; Jean Meynadier; Mohsen Alirezai; Andrew Y Finlay; Pascale Soto; Michel Poncet; M Verschoore; A Clucas
Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life.
The British journal of dermatology 1998;139 Suppl 52():26-33.
1998: Christopher E M Griffiths; Philippe Ancian; JD Humphries; Michel Poncet; E Rizova; S Michel; A Clucas
Adapalene 0.1% gel and adapalene 0.1% cream stimulate retinoic acid receptor mediated gene transcription without significant irritative effects in the skin of healthy human volunteers.
The British journal of dermatology 1998;139 Suppl 52():12-6.
1997: A Clucas; M Verschoore; V Sorba; Michel Poncet; M Baker; Janusz Czernielewski
Adapalene 0.1% gel is better tolerated than tretinoin 0.025% gel in acne patients.
Journal of the American Academy of Dermatology 1997;36(6 Pt 2):S116-8.
1997: D Caron; V Sorba; A Clucas; M Verschoore
Skin tolerance of adapalene 0.1% gel in combination with other topical antiacne treatments.
Journal of the American Academy of Dermatology 1997;36(6 Pt 2):S113-5.
1997: D Caron; V Sorba; N Kerrouche; A Clucas
Split-face comparison of adapalene 0.1% gel and tretinoin 0.025% gel in acne patients.
Journal of the American Academy of Dermatology 1997;36(6 Pt 2):S110-2.
1997: M Verschoore; Michel Poncet; Janusz Czernielewski; V Sorba; A Clucas
Adapalene 0.1% gel has low skin-irritation potential.
Journal of the American Academy of Dermatology 1997;36(6 Pt 2):S104-9.